# Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience

> **NCT05182203** · — · COMPLETED · sponsor: **Tuen Mun Hospital** · enrollment: 1732 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Drug Use

## Interventions

- **DRUG:** biologic/targeted therapy

## Key facts

- **NCT ID:** NCT05182203
- **Lead sponsor:** Tuen Mun Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 1732 (ACTUAL)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05182203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05182203, "Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05182203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*